Insights from 2023 ASCO® Annual Meeting

 

Hematology
12:35

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Treatment Options for Patients With Myeloma and Renal Failure”

FEATURING Claudio Cerchione
  • 1,013 views
  • August 18, 2023
  • 5
05:23

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Summary of Treatment Options for Patients With Myeloma and Renal Failure”

FEATURING Claudio Cerchione
  • 24 views
  • August 18, 2023
04:24

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "RW Dosing Patterns & Outcomes Among CLL Pts Treated With Ibrutinib With/Without a Dose Adjustment"

FEATURING Kerry Rogers
  • 88 views
  • August 3, 2023
09:09

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Updated TRIMM-2 Results - Talquetamab + Daratumumab in Patients With R/R MM"

FEATURING Bhagirathbhai Dholaria
  • 154 views
  • July 16, 2023
  • 1
04:32

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Phase 1b/2 CARTITUDE-1 Study Final Results - Ciltacabtagene Autoleucel in Heavily Pretreated Patients With R/R MM"

FEATURING Yi Lin
  • 144 views
  • July 14, 2023
06:38

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Updated Results From EPCORE NHL-1 - Effect of Follow-Up Time on the Ability of Subcutaneous Epcoritamab to Induce Deep & Durable CRs in Patients With R/R LBCL"

FEATURING Yasmin Karimi
  • 170 views
  • July 14, 2023
  • 2
10:36

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Epcoritamab + R² Regimen and Responses in High-Risk FL Regardless of POD24 Status"

FEATURING Reid Merryman
  • 289 views
  • June 27, 2023
  • 2
20:11

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "Combination Therapy Trials in Myeloma - A Discussion of Key Oral Abstracts"

FEATURING Andrzej Jakubowiak
  • 315 views
  • June 27, 2023
  • 1
09:21

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Outcomes of 3- vs. 5-Day Schedule of Consolidation Cytarabine in Adults With AML"

FEATURING Sravanti Rangaraju
  • 137 views
  • June 23, 2023
  • 2
12:24

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Real-World Outcomes of Brexu-Cel for R/R MCL - A CIBMTR Subgroup Analysis by Prior Treatment"

FEATURING Swetha Kambhampati
  • 63 views
  • June 22, 2023
11:20

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "First Phase 3 Results From CARTITUDE-4 - Cilta-Cel vs. Standard of Care (PVd or DPd) in Lenalidomide-Refractory MM"

FEATURING Binod Dhakal
  • 393 views
  • June 22, 2023
  • 2
10:37

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Outcomes of 10-Day Decitabine With Venetoclax for AML"

FEATURING Alexander Coltoff
  • 156 views
  • June 22, 2023
  • 2
06:51

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Efficacy of COVID Vaccinations in Patients With CLL"

FEATURING Kerry Rogers
  • 104 views
  • June 20, 2023
  • 2
14:34

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "IMerge - Results From a Ph3 Study of Imetelstat in Pts With Heavily Transfusion Dependent Non-Del(5q) LR-MDS R/R to ESAs"

FEATURING Amer Zeidan
  • 419 views
  • June 20, 2023
  • 3
14:44

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Chemo-Free Treatment With Inotuzumab Ozogamicin & Blinatumomab for Older Adults With Newly Diagnosed, Ph-, CD22+ B-ALL (Alliance A041703)"

FEATURING Matthew Wieduwilt
  • 130 views
  • June 20, 2023
  • 1
10:27

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Rates of CRS and ICANS From CIBMTR Data on US Subjects With Lymphoma Following CAR-T"

FEATURING John DiPersio
  • 573 views
  • June 20, 2023
  • 3
05:00

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Results of MOLTO, a Multicenter, Open Label, Ph2 Clinical Trial Evaluating Venetoclax, Atezolizumab, + Obinutuzumab in Richter Syndrome"

FEATURING Anna Frustaci
  • 30 views
  • June 16, 2023
09:57

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "KRd vs. Elotuzumab + KRd in Transplant-Eligible Pts With NDMM - Post-Induction Response and MRD Results From an Open-Label Randomized Phase 3 Study"

FEATURING Stefan Knop
  • 103 views
  • June 15, 2023
03:40

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Long-Term Safety With ≥12 Months of Pirtobrutinib in R/R B-Cell Malignancies"

FEATURING Catherine Coombs
  • 105 views
  • June 15, 2023
12:47

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "Experts Discuss Key Abstracts in CLL"

FEATURING Susan O'Brien, Catherine Coombs
  • 2,069 views
  • June 15, 2023
  • 7
07:06

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Putting the CAR-T Before the Horse - Improving Access to Better Outcomes"

FEATURING Leyla Shune
  • 453 views
  • June 15, 2023
  • 4
06:27

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Safety and Efficacy of Standard of Care Cilta-Cel for R/R MM"

FEATURING Doris Hansen
  • 112 views
  • June 15, 2023
04:31

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Impact of Bridging Therapy on Outcome of R/R MM With Ide-Cel CAR-T Therapy - Real-World Experience From the US Myeloma CAR-T Consortium"

FEATURING Aimaz Afrough
  • 139 views
  • June 15, 2023
03:42

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "BELLWAVE-003 - A Phase 2 Dose Escalation, Confirmation, and Cohort Expansion Study of Nemtabrutinib in Hematologic Malignancies"

FEATURING Guilherme Perini
  • 190 views
  • June 14, 2023
12:33

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Minimizing Uncertainty in Multiple Myeloma - Are We Getting Closer to a Cure?"

FEATURING Krina Patel
  • 446 views
  • June 14, 2023
  • 3
05:27

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Efficacy and Safety Results From the Ph3 COMMANDS Trial - Evaluating Luspatercept vs. Epoetin Alfa in ESA‑Naïve Transfusion-Dependent Pts With LR-MDS"

FEATURING Matteo Della Porta
  • 268 views
  • June 14, 2023
08:46

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Updated Results From XPORT-MF-034 - Selinexor + Ruxolitinib in JAKi Treatment-Naïve Patients With Myelofibrosis"

FEATURING Haris Ali
  • 205 views
  • June 14, 2023
  • 1
11:54

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Betting on BCMA in Multiple Myeloma"

FEATURING Ravi Vij
  • 219 views
  • June 14, 2023
  • 1
16:24

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Much Ado About ALL CAR-T - Highlights of Oral Abstracts"

FEATURING Rawan Faramand
  • 70 views
  • June 14, 2023
  • 1
16:02

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Managing the Toxicities and Supportive Care Associated With Novel Acute Myeloid Leukemia Agents"

FEATURING Gabriel Mannis
  • 240 views
  • June 14, 2023
  • 1
10:15

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "A Ph1 Trial of Dose-Adjusted EPOCH + Inotuzumab Ozogamicin in Adults With R/R B-ALL"

FEATURING Noam Kopmar
  • 131 views
  • June 14, 2023
08:21

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "The Phase 2 KEYNOTE-B68 Trial - Efficacy & Safety of Pembro Every 6 Weeks in R/R cHL or Primary Mediastinal B-Cell Lymphoma"

FEATURING Andrew Mcdonald
  • 160 views
  • June 14, 2023
  • 2
06:18

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Pirtobrutinib in cBTKi Pre-Treated MCL - Updated Results & Subgroup Analysis From the Phase 1/2 BRUIN Study With 2 Years of Survival Follow-Up"

FEATURING Nirav Shah
  • 247 views
  • June 14, 2023
  • 1
14:09

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "Multiple Myeloma Highlights and Clinical Perspectives"

FEATURING Hamza Hashmi
  • 1,076 views
  • June 14, 2023
  • 4
06:00

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "ASC2ESCALATE: A US Phase 2, Single-Arm, Dose-Escalation Study of Asciminib Monotherapy in Pts With CML-CP Previously Treated With 1 Prior TKI"

FEATURING Jorge Cortés
  • 83 views
  • June 14, 2023
  • 2
08:58

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Zanubrutinib + Obinutuzumab vs. Obinutuzumab in Patients With R/R FL - Updated Analysis of the ROSEWOOD Study"

FEATURING Christopher Flowers
  • 508 views
  • June 9, 2023
  • 2
15:47

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "SWOG S1826 - Rationale, Results, and Clinical Perspectives on Nivo-AVD vs. BV-AVD in Advanced Stage cHL"

FEATURING Andrew Evens
  • 845 views
  • June 9, 2023
  • 5
06:34

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "A Matching-Adjusted Indirect Comparison of the Efficacy and Safety of Acalabrutinib vs. Zanubrutinib in R/R CLL"

FEATURING Adam Kittai
  • 558 views
  • June 9, 2023
  • 4
04:06

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "PERSIST-2 Landmark OS Analysis - Spleen Volume Reduction Predicts OS in Myelofibrosis Pts on Pacritinib, But Not Best Available Therapy"

FEATURING Helen Ajufo
  • 318 views
  • June 9, 2023
  • 1
16:14

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Merging Molecular and Aging Assessments to Guide Therapy in Older Patients With Myeloma"

FEATURING Shakira Grant
  • 99 views
  • June 9, 2023
10:06

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Results of A041702, an Alliance Phase 3 Study of IVO vs. IO for Previously Untreated Older Patients With CLL and Impact of COVID-19"

FEATURING Jennifer Woyach
  • 756 views
  • June 9, 2023
  • 6
11:35

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Updated Phase I Study Results of PHE885, a T-Charge Manufactured BCMA-Directed CAR T-Cell Therapy, for Pts With R/R MM"

FEATURING Adam Sperling
  • 230 views
  • June 9, 2023
05:09

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Radiation Oncology Perspective on Primary CNS Lymphoma - A Patient-Centered Approach to Treatment Selection"

FEATURING Andrea Ng
  • 170 views
  • June 9, 2023
  • 1
05:22

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Five-Year Follow-Up Update of Defined-Composition CD19 CAR T-Cell Therapy for R/R CLL"

FEATURING Emily Liang
  • 214 views
  • June 9, 2023
  • 1
11:12

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "SWOG S1826, a Randomized Study of Nivo-AVD vs. Brentuximab Vedotin-AVD in Advanced Stage cHL"

FEATURING Alex Herrera
  • 1,165 views
  • June 8, 2023
  • 13
12:36

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Myeloid for Measure - New Therapeutics in MDS and AML"

FEATURING Anand Patel
  • 884 views
  • June 8, 2023
  • 5
20:19

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Highlights of Hematologic Malignancies - Multiple Myeloma"

FEATURING Aneel Paulus
  • 1,776 views
  • June 8, 2023
  • 5
09:45

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Therapeutic Options for Pts With Primary Refractory/Early Relapsed DLBCL"

FEATURING Manali Kamdar
  • 635 views
  • June 7, 2023
  • 1
09:38

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Long-Term Outcomes of Adults With R/R B-ALL Treated With Brexu-Cel in ZUMA-3 - Impact of Age, Prior Therapies, and Subsequent Transplant"

FEATURING Bijal Shah
  • 181 views
  • June 7, 2023
  • 5
09:18

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Primary OS Analysis of the Phase 3 Randomized ZUMA‑7 Study of Axi-Cel vs. Standard‑of-Care Therapy in R/R LBCL"

FEATURING Jason Westin
  • 1,511 views
  • June 7, 2023
  • 3
02:52

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Results From a Phase 1 Clinical Study of the All-Oral Regimen of CC-486 and Venetoclax for AML"

FEATURING Maria Amaya
  • 427 views
  • June 7, 2023